SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001017062-01-500953
Filing Date
2001-12-21
Accepted
2001-12-21 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D dsc13d.txt SC 13D 30769
  Complete submission text file 0001017062-01-500953.txt   32867
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filed by) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 51 UNIVERSITY STREET SEATLE WA 98101
Business Address 51 UNIVERSITY ST SEATTLE WA 98101 2065870430
IMMUNEX CORP /DE/ (Subject) CIK: 0000719529 (see all company filings)

IRS No.: 510346580 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-35229 | Film No.: 1822006
SIC: 2836 Biological Products, (No Diagnostic Substances)